Products for Research Use Only
RegisterLogin

GW2580

CAT: 0804-HY-10917-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-10917-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
GW2580 is an orally bioavailable and selective inhibitor of c-Fms kinase which completely inhibits human cFMS kinase in vitro at 0.06 μM. GW2580 acts as a competitive inhibitor of ATP binding to the cFMS kinase and inhibits colony-stimulating-factor-1 signaling[1].
CAS Number
870483-87-7
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
C-Fms
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/GW2580.html
Purity
99.90
Solubility
DMSO : 33.33 mg/mL (ultrasonic) |Ethanol : < 1 mg/mL (ultrasonic)
Smiles
NC1=NC(N)=C(CC2=CC(OC)=C(OCC3=CC=C(OC)C=C3)C=C2)C=N1
Molecular Formula
C20H22N4O3
Molecular Weight
366.41
Precautions
H302, H315, H319, H335
References & Citations
[1]Conway JG, et al. Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580. Proc Natl Acad Sci U S A. 2005 Nov 1;102 (44) :16078-83.|[2]Priceman SJ, et al. Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy. Blood. 2010 Feb 18;115 (7) :1461-71|[3]Conway JG, et al. Effects of the cFMS kinase inhibitor 5- (3-methoxy-4- ((4-methoxybenzyl) oxy) benzyl) pyrimidine-2,4-diamine (GW2580) in normal and arthritic rats. J Pharmacol Exp Ther. 2008 Jul;326 (1) :41-50.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Alternative Products

CatalogName
1740-5GW2580
A11959-200GW2580 200mg
A11959-50GW2580 50mg
A11959-5GW2580 5mg
A11959-100GW2580 100mg

Popular Products